CI INVESTMENTS INC.

Position in ROIV — Roivant Sciences Ltd.

CIK 1163648 TORONTO, Z4

Position in ROIV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$215,206

+$206,098 QoQ

Shares Held

6,081

+910.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#355

of 494 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CI INVESTMENTS INC. holds $64,367,800 across 12 Biotechnology names. ROIV ranks #12 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	299,091	$21,130,779
2	VRTX	Vertex Pharmaceuticals Inc / Ma	28,775	$14,293,405
3	REGN	Regeneron Pharmaceuticals, Inc.	20,415	$12,729,569
4	RPRX	Royalty Pharma plc	178,247	$9,994,309
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,157	$2,756,531
6	MRNA	Moderna, Inc.	12,208	$854,926
7	INCY	Incyte Corp	6,522	$739,333
8	ARGX	Argenx SE	681	$631,811

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$215,206	6,081	+910.1%	Shares	Sole	2026-08-13
2025-09-30	$9,108	602	+3.1%	Shares	Sole	2025-11-12
2025-06-30	$6,581	584	-9.6%	Shares	Sole	2025-08-12
2025-03-31	$6,518	646	-4.6%	Shares	Sole	2025-05-13
2024-12-31	$8,008	677	-94.2%	Shares	Sole	2025-02-12
2024-09-30	$133,610	11,578	+2.0%	Shares	Sole	2024-11-12
2024-06-30	$120,032	11,356	-7.9%	Shares	Sole	2024-08-12
2024-03-31	$130,000	12,334	+54.5%	Shares	Sole	2024-05-13
2023-12-31	$89,637	7,982	+1096.7%	Shares	Sole	2024-02-12
2023-09-30	$7,790	667	+15.6%	Shares	Sole	2023-11-13
2023-06-30	$5,816	577	+2936.8%	Shares	Sole	2023-08-11
2023-03-31	$140	19	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.